HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

HLA and HPA typing in idiopathic thrombocytopenic purpura patients treated with Kami-kihi-to.

Abstract
We performed human leukocyte antigen (HLA) and human platelet antigen (HPA) in patients with Kami-kihi-to-responsive idiopathic thrombocytopenic purpura. The HLA-A2, A61 and Cw1 were significantly increased in responders compared with nonresponders, as were HLA DRB1 *0901, DRB1 *1502, and DPB1 *0501. In contrast, HLA DPB1 *0201 and DPB1 *0901 were significantly decreased in responders. The a/b genotype of HPA-2 and a/a genotype of HPA-3 were markedly increased in nonresponders, and anti-GPIb antibody was also increased. These results suggest that HLA, HPA, and anti-GP antibody studies may predict the response of idiopathic thrombocytopenic purpura to Kami-kihi-to.
AuthorsT Matsuzaki, S Nomura, M Yamaoka, Y Ozaki, C Yoshimura, G L Xie, K Katsura, H Kagawa, T Ishida, S Fukuhara
JournalThe American journal of Chinese medicine (Am J Chin Med) Vol. 26 Issue 2 Pg. 191-8 ( 1998) ISSN: 0192-415X [Print] Singapore
PMID9799971 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, Human Platelet
  • Drugs, Chinese Herbal
  • HLA Antigens
  • HLA-A2 Antigen
  • HLA-B Antigens
  • HLA-B61 antigen
  • HLA-C Antigens
  • HLA-DR Antigens
  • HLA-DRB1 Chains
Topics
  • Antigens, Human Platelet (classification, genetics)
  • Drugs, Chinese Herbal (therapeutic use)
  • Female
  • HLA Antigens (classification, genetics)
  • HLA-A2 Antigen (classification, genetics)
  • HLA-B Antigens (classification, genetics)
  • HLA-C Antigens (classification, genetics)
  • HLA-DR Antigens (classification, genetics)
  • HLA-DRB1 Chains
  • Histocompatibility Testing
  • Humans
  • Male
  • Purpura, Thrombocytopenic, Idiopathic (drug therapy, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: